Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle

ClinicalTrials.gov ID: NCT00729716

Public ClinicalTrials.gov record NCT00729716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study to Investigate the Efficacy and Safety of BioCart™II in the Treatment of Symptomatic Cartilage Defects of the Femoral Condyle in Comparison With Microfracture

Study identification

NCT ID: NCT00729716
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: ProChon Biotech Ltd; Industry
Enrollment: 40 participants

Conditions and interventions

Conditions

Symptomatic Cartilage Defects of the Femoral Condyle

Interventions

BioCart™II Biological
Microfracture Procedure

Biological · Procedure

Eligibility (public fields only)

Age range: 16 Years to 60 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 30, 2008
Primary completion: Apr 30, 2012
Completion: Apr 30, 2015
Last update posted: Apr 16, 2012

2008 – 2015

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
Tucson Orthopaedic Institute	Tucson	Arizona	85712	—
Southeastern Orthopedic Center	Savannah	Georgia	31405	—
Sinai Hospital of Baltimore	Baltimore	Maryland	21215	—
Mount Sinai Medical Center	New York	New York	10029-6754	—
University Orthopedics Center	Altoona	Pennsylvania	16602	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00729716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 16, 2012 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00729716 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →